Biocept (BIOC)

Biocept's (BIOC) CEO Michael Nall on Q2 2017 Results - Earnings Call Transcript
Aug. 10, 2017 | Price: Free! | Source: Seeking Alpha

Biocept's (BIOC) CEO Michael Nall on Q1 2017 Results - Earnings Call Transcript
May 13, 2017 | Price: Free! | Source: Seeking Alpha

Biocept's (BIOC) CEO Michael Nauman on Q1 2017 Results - Earnings Call Transcript
March 7, 2017 | Price: Free! | Source: Seeking Alpha

Recent filings

Amendments to Articles of Incorporation or - Sept. 29, 2017

Departure of Directors or Certain - Sept. 8, 2017

Biocept Just Received a Notice of Effectiveness - Aug. 30, 2017

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 30, 2017

Registration statement under Securities Act of 1933 - Aug. 18, 2017

Bin Li just provided an update on activist position in Biocept - Aug. 17, 2017

Major owner of Biocept just declared owning 3,147,667 shares of Biocept - Aug. 17, 2017

Notice of Exempt Offering of Securities, item 06b - Aug. 14, 2017

Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Aug. 14, 2017

Biocept Reports Second Quarter 2017 Financial Results - Aug. 10, 2017

Entry into a Material Definitive - Aug. 10, 2017

Biocept director was just granted 15,000 options - June 2, 2017

Biocept director was just granted 15,000 options - June 2, 2017

Biocept director was just granted 15,000 options - June 2, 2017

Biocept director was just granted 15,000 options - June 2, 2017

Biocept's CEO & President just picked up 50,000 shares - June 2, 2017

Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - May 15, 2017

Securities to be offered to employees in employee benefit plans - May 15, 2017

Biocept Reports First Quarter 2017 Financial Results - May 11, 2017

Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017

Notice of Exempt Offering of Securities, item 06b - April 10, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept director was just granted 4,166 options - April 3, 2017

Biocept releases salary data. CEO sees compensation fall -14% - March 30, 2017

Biocept Announces Pricing Of $9.3 Million Financing - March 30, 2017

Biocept director just picked up 5,667 shares - March 29, 2017

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2017

Biocept Just Filed Its Annual Report: 12. Net Loss per Co... - March 28, 2017

Shareholder Director - March 23, 2017

CFO of Biocept was just granted 16,383 options - March 22, 2017

Biocept's CEO & President was just granted 16,333 options - March 22, 2017

Biocept Reports Fourth Quarter And Full Year 2016 Financial Results - March 7, 2017

Biocept's Sr VP Comm. Operations was just granted 50,000 options - Feb. 28, 2017

Biocept's Sr VP Comm. Operations just declared owning 2,900 shares of Biocept - Feb. 16, 2017

Biocept’S Ceo Issues Letter To Stockholders - Feb. 9, 2017

Bin Li just provided an update on activist position in Biocept - Jan. 27, 2017

Major owner of Biocept just disposed of 1,681,000 shares - Jan. 26, 2017

On November - Jan. 25, 2017

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Jan. 11, 2017

Notice of Delisting or - Dec. 2, 2016

Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Nov. 10, 2016

Biocept Reports 2016 Third Quarter Financial Results - Nov. 9, 2016

Termination of a Material Definitive - Nov. 4, 2016

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Oct. 28, 2016

Major owner of Biocept just declared owning 1,681,000 shares of Biocept - Oct. 24, 2016

Daniel V. Tierney just provided an update on share ownership of Biocept - Oct. 24, 2016

Biocept's SR VP of R&D and CSO just picked up 45,000 shares - Oct. 21, 2016

Biocept director just picked up 90,909 shares - Oct. 21, 2016

Biocept director just picked up 227,272 shares - Oct. 21, 2016

CFO of Biocept just picked up 36,363 shares - Oct. 21, 2016

Major owner of Biocept just picked up 227,272 shares - Oct. 21, 2016

Biocept director just picked up 13,636 shares - Oct. 21, 2016

Biocept director just picked up 20,000 shares - Oct. 21, 2016

Biocept director just picked up 4,545 shares - Oct. 21, 2016

Biocept director just picked up 50,000 shares - Oct. 21, 2016

Biocept's Sr VP & Sr Med Director just picked up 10,000 shares - Oct. 21, 2016

Biocept's CEO & President just picked up 36,363 shares - Oct. 21, 2016

Bin Li just provided an update on activist position in Biocept - Oct. 20, 2016

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of Biocept - Oct. 17, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Oct. 14, 2016

Post-effective amendment adding exhibits to registration statement [Rule 462(d)] - Oct. 14, 2016

Biocept Just Received a Notice of Effectiveness - Oct. 13, 2016

General form for registration of securities under the Securities Act of 1933 - Oct. 6, 2016

General form for registration of securities under the Securities Act of 1933 - Sept. 29, 2016

Biocept: Risks Relating To Our Financial Condition And Capital Requirements - Sept. 29, 2016

Other definitive proxy statements - Aug. 31, 2016

General form for registration of securities under the Securities Act of 1933 - Aug. 12, 2016

Other preliminary proxy statements - Aug. 11, 2016

Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - Aug. 5, 2016

Securities to be offered to employees in employee benefit plans - Aug. 5, 2016

Biocept Reports 2016 Second Quarter Financial Results - Aug. 2, 2016

CFO of Biocept just picked up 75,000 shares - Aug. 1, 2016

Departure of Directors or Certain - Aug. 1, 2016

CFO of Biocept just declared ownership of no shares of Biocept - July 27, 2016

Biocept Appoints Timothy C. Kennedy As Chief Financial Officer And Senior Vice President Of Operations - July 27, 2016

Biocept's SR VP of R&D and CSO just picked up 50,000 shares - July 7, 2016

Departure of Directors or Certain - July 7, 2016

Biocept's Sr VP & Sr Med Director just picked up 50,000 shares - July 7, 2016

Biocept's CEO & President just picked up 75,000 shares - July 7, 2016

Submission of Matters to a Vote of Security - June 29, 2016

Notice of Delisting or - June 17, 2016

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - May 26, 2016

Biocept releases salary data. CEO sees compensation fall -29% - May 18, 2016

Biocept Just Filed Its Quarterly Report: 9. Net Loss per Com... - May 13, 2016

Biocept Reports 2016 First Quarter Financial Results - May 12, 2016

Biocept just filed a prospectus, suggesting it plans to soon issue some securities - May 10, 2016

Biocept Just Received a Notice of Effectiveness - May 10, 2016

Statement of acquisition of beneficial ownership by individuals - May 6, 2016

Biocept director just picked up 100,000 shares - May 5, 2016

Major owner of Biocept just picked up 614,273 shares - May 5, 2016

Biocept director just picked up 25,000 shares - May 5, 2016

Biocept director just picked up 50,000 shares - May 5, 2016

Major owner of Biocept just declared owning 14,012 shares of Biocept - May 5, 2016

Post-Effective amendments for registration statement - May 4, 2016

Prospectus [Rule 424(b)(5)] - April 29, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. BlackRock Fund Advisors 1,498 N/A Sept. 30, 2016
2. DEUTSCHE BANK AG\ 3,400 N/A June 30, 2017
3. VANGUARD GROUP INC 764,351 N/A June 30, 2017
4. Citadel Advisors LLC 22,041 N/A June 30, 2017
5. MetLife Securities, Inc 167 N/A Dec. 31, 2016
6. KCG Holdings, Inc. 17,372 N/A June 30, 2017
7. BlackRock Institutional Trust Company, N.A. 56,732 N/A Dec. 31, 2016
8. MORGAN STANLEY 334 N/A Dec. 31, 2016
9. GARRISON BRADFORD & ASSOCIATES INC 25,546 N/A June 30, 2017
10. GEODE CAPITAL MANAGEMENT, LLC 67,373 N/A June 30, 2017
11. BANK OF MONTREAL /CAN/ 85,000 N/A June 30, 2017
12. NORTHERN TRUST CORP 16,490 N/A June 30, 2017
13. State Street Corp 10,000 N/A June 30, 2017
14. UBS Group AG 1,189 N/A March 31, 2017
15. SUSQUEHANNA INTERNATIONAL GROUP, LLP 36,700 N/A June 30, 2017
16. GROUP ONE TRADING, L.P. 91,400 N/A June 30, 2017
17. Advisory Services Network, LLC 334 N/A Sept. 30, 2017
18. RAYMOND JAMES & ASSOCIATES 27,050 N/A June 30, 2017
19. ROYAL BANK OF CANADA 130 N/A Sept. 30, 2016
20. Creative Planning 510,502 N/A Sept. 30, 2017
21. US BANCORP \DE\ 24,755 N/A June 30, 2017
22. BlackRock Inc. 762,950 N/A June 30, 2017
23. Bank of New York Mellon Corp 40,314 N/A June 30, 2017
24. BlackRock Inc. 774,517 N/A March 31, 2017
25. Bank of New York Mellon Corp 35,979 N/A March 31, 2017
26. MORGAN STANLEY 10,334 N/A March 31, 2017
27. Bank of New York Mellon Corp 40,314 N/A June 30, 2017

Biocept (BIOC)

140
 


Feedback